LEADER 02125oam 2200505 a 450 001 9910702324603321 005 20150224143230.0 035 $a(CKB)5470000002426915 035 $a(OCoLC)822057471 035 $a(EXLCZ)995470000002426915 100 $a20121219d2012 ua 0 101 0 $aeng 135 $aurbn||||a|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aOne year after President Obama's Gulf of Mexico 6-month moratorium officially lifted$b[electronic resource] $eexamining the lingering impacts on jobs, energy production, and local economies : oversight hearing before the Committee on Natural Resources, U.S. House of Representatives, One Hundred Twelfth Congress, first session, Wednesday, October 12, 2011 210 1$aWashington :$cU.S. G.P.O.,$d2012. 215 $a1 online resource (iii, 63 pages) $cillustrations, maps 300 $aTitle from title screen (viewed on Dec. 19, 2012). 300 $aPaper version available for sale by the Supt. of Docs., U.S. G.P.O. 300 $a"Serial no. 112-69." 320 $aIncludes bibliographical references. 517 $aOne year after President Obama's Gulf of Mexico 6-month moratorium officially lifted 606 $aOffshore oil and gas leases$zMexico, Gulf of 606 $aOffshore oil well drilling$zMexico, Gulf of 606 $aOffshore gas well drilling$zMexico, Gulf of 606 $aOffshore gas well drilling$2fast 606 $aOffshore oil and gas leases$2fast 606 $aOffshore oil well drilling$2fast 607 $aGulf of Mexico$2fast 615 0$aOffshore oil and gas leases 615 0$aOffshore oil well drilling 615 0$aOffshore gas well drilling 615 7$aOffshore gas well drilling. 615 7$aOffshore oil and gas leases. 615 7$aOffshore oil well drilling. 801 0$bGPO 801 1$bGPO 801 2$bOCLCF 801 2$bGPO 906 $aBOOK 912 $a9910702324603321 996 $aOne year after President Obama's Gulf of Mexico 6-month moratorium officially lifted$93548046 997 $aUNINA LEADER 03807nam 22006255 450 001 9910300183703321 005 20200701093547.0 010 $a3-319-07410-5 024 7 $a10.1007/978-3-319-07410-8 035 $a(CKB)3710000000269884 035 $a(EBL)1965119 035 $a(SSID)ssj0001372837 035 $a(PQKBManifestationID)11782344 035 $a(PQKBTitleCode)TC0001372837 035 $a(PQKBWorkID)11310810 035 $a(PQKB)11298279 035 $a(DE-He213)978-3-319-07410-8 035 $a(MiAaPQ)EBC1965119 035 $a(PPN)182092763 035 $a(EXLCZ)993710000000269884 100 $a20141031d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aWhite Coat Hypertension $eAn Unresolved Diagnostic and Therapeutic Problem /$fby Giuseppe Mancia, Guido Grassi, Gianfranco Parati, Alberto Zanchetti 205 $a1st ed. 2015. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015. 215 $a1 online resource (153 p.) 300 $aDescription based upon print version of record. 311 $a3-319-07409-1 320 $aIncludes bibliographical references. 327 $a1 Historical Notes -- 2 Definition, Terminology and Prevalence -- 3 Diagnostic Approach to white coat effect and white coat hypertension -- 4 Neurogenic and Non-neurogenic Mechanisms -- 5 Predictive Factors -- 6 White coat hypertension and cardiovascular morbidity and mortality -- 7 White coat hypertension and Target Organ Damage -- 8 White Coat Hypertension, metabolic risk factors, and cardiovascular risk profile -- 9 To Treat or Not To Treat?. 330 $aThis book addresses all aspects of white coat hypertension ? the phenomenon of raised blood pressure in a medical setting yet not elsewhere ? from its history to its pathophysiology, diagnosis and treatment. White coat hypertension is a common condition, accounting for 30?40% of the overall hypertensive population. While many studies have addressed this condition, controversy still exists over whether it causes an increased risk to sufferers and should be treated.  In the volume neurogenic and non-neurogenic mechanisms are discussed and the significance of various predictive factors, evaluated. The association of white coat hypertension with dysmetabolic risk factors, new-onset diabetes and other conditions is carefully reviewed. Further chapters consider the occurrence of asymptomatic organ damage and cardiovascular outcomes in affected patients, and helpful guidance is also provided on the controversial issue of when to treat and when not to treat. White Coat Hypertension is based largely on work done during the past 30 years by renowned researchers working in Milan, who have made key contributions in improving knowledge of the condition and whose work is well known across the world. 606 $aCardiology 606 $aDiabetes 606 $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037 606 $aDiabetes$3https://scigraph.springernature.com/ontologies/product-market-codes/H33045 615 0$aCardiology. 615 0$aDiabetes. 615 14$aCardiology. 615 24$aDiabetes. 676 $a610 676 $a616.12 676 $a616.46 676 $a616462 700 $aMancia$b Giuseppe$4aut$4http://id.loc.gov/vocabulary/relators/aut$01062846 702 $aGrassi$b Guido$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aParati$b Gianfranco$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aZanchetti$b Alberto$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910300183703321 996 $aWhite Coat Hypertension$92528726 997 $aUNINA